EQUITY RESEARCH MEMO

InfoBionic.Ai

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)60/100

InfoBionic.Ai is a Boston-based digital health company pioneering AI-driven remote cardiac monitoring through its MoMe ARC® platform. By converting complex cardiac data into actionable clinical insights, the platform enables hospital-grade diagnostics from any care setting, aiming to improve patient outcomes through earlier interventions. Founded in 2015, the company operates in the rapidly expanding remote monitoring and AI/ML healthcare sectors, but remains private with limited publicly available financial or operational details.

Upcoming Catalysts (preview)

  • Q2 2026FDA Clearance for Expanded Indications (e.g., Pediatric or Extended Wear)70% success
  • Q3 2026Strategic Partnership with Major Health System or Telehealth Platform50% success
  • Q4 2026Publication of Key Clinical Validation Study in Peer-Reviewed Journal60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)